Table 2 Confirmed renal disease QTL of genetic rat models by consomic and/or congenic studies
From: Mapping genetic determinants of kidney damage in rat models
Cross/reference consomics or congenics | Treatment | Phenotype | Confirmed QTL on RNO |
|---|---|---|---|
ACI.FHH-(D1Rat74-D1Rat90) or Rf-1A | 8.0% NaCl/ | Proteinuria | 1, 3 |
ACI.FHH-(D1Rat298-D1Rat90) or Rf-1A | L-NAME/ | Albuminuria | 1, 3 |
ACI.FHH-D1Mit34/Rat156 or ACI.FHH-Rf1B | Nx | Glomerular damage | 1, 3 |
ACI.FHH-(D1Rat324-D1Rat156) or Rf-1B | Autoregulation of renal blood flow | 1 | |
ACI.FHH-(D1Rat384-D1Rat156) or Rf-1B | Susceptibility to renal failure | 1+3, 1+14 | |
ACI.FHH-(D3Wox2-D3Rat59) or Rf-3 | |||
Rf-3_b (D3Got102-D3Got121) | |||
ACI.FHH-(D1Rat475-D1Rat90)/(D3Rat84-D3Rat59) or Rf-1A+3 | |||
ACI.FHH-(D1Mit18-D1Rat90)/(D14Mit11-D14Rat33/D14Rat65-D14Rat90) or ACI.FHH-Rf-1+4 | |||
ACI.FHH-(D1Mit18-D1Rat90)/(D14Rat98-D14Hmgc18)/Mcwi or Rf-1a+4_a | |||
ACI.FHH-(D1Mit18-D1Rat90)/(D3Rat84-D3Rat59)/(D14Mit11-D14Rat33/D14Rat65-D14Rat90) or Rf-1 + 3+4 | |||
ACI.FHH-(D1Mit18-D1Rat90)/(D3Rat6-D3Got149)/(D14Mit11-D14Rat33/D14Rat65-D14Rat90) or Rf-1+3+4_a | |||
ACI.FHH-(D1Mit18-D1Rat90)/(D3Got102-D3Got149)/(D14Mit11-D14Rat33/D14Rat65-D14Rat90) or Rf-1+3+4_b | |||
ACI.FHH-(D1Mit18-D1Mit8)/(D14Mit11-D14Hmgc14b/D14Rat65-D14Rat90) or Rf-1B+1 | |||
FHH.1BNAR+ | Normal salt or 8.0% NaCl L-NAME | Albuminuria | 1, 15, 16, 18 |
FHH-1BN | Proteinuria | 1, 14, 15, 16 | |
FHH-15BN | Glomerular injury | 1, 15, 16, 18 | |
FHH-16BN | Blocked medullary tubules (males) | 15, 16 | |
FHH-18BN | Autoregulation of renal blood flow | 1 | |
FHH-20BN | |||
FHH.BN-Rab38 | |||
LH × BN 127 | |||
LH-13BN | 0.3% NaCl | Proteinuria (may depend on higher BP) | 13 |
BN-13LH | |||
MWF-6SHR | 0.2% NaCl | Albuminuria | 6, 8, 6+8 |
MWF-8SHR | Total nephron number | 6, 6+8 | |
MWF-6SHR8SHR | Renal interstitial fibrosis | 6, 8 (females) | |
SHR-6MWF | Glomerulosclerosis | 6, 6+8 | |
SHR-8MWF | Tubulointerstitial damage | 6, 8 | |
Podocyte alterations | 6, 8, 6+8 | ||
SBH.1SBN | Normal diet | Proteinuria | 1, 2, 17, 20 |
SBH.2SBN | |||
SBH.17SBN | |||
SBH.20SBN | |||
SBH.XSBN | |||
SHR × BN 170 | |||
SHR.BN-D1Mit3/Igf2 | 1%NaCl/0.2% KCl, DOCA | Renal damage such as proteinuria and glomerular injury | 1 |
SHRSPwch1.0 | 1% NaCl, stroke-permissive diet | Albuminuria | 1 |
SHRSP.WKY-(D1Rat44-D1Arb21) or SHRSPwch1.5 | Glomerulosclerosis | 1 | |
SHRSP.WKY-(Apbb1-D1Arb21) or SHRSPwch1.8 | |||
SHRSP.WKY-(D1Mgh5-D1Rat44) or SHRSPwch1.9 | |||
SHRSP.WKY-(D1Mgh5-D1Wox29) or SHRSPwch1.11 | |||
S.SHR(2) | 0.3% or 2% NaCl | Proteinuria/albuminuria | 2, 6 (QTL2), 8, 9, 13 |
S.SHR(6) | Glomerular injury | 2, 8 | |
S.SHR(8) | Tubular and interstitial injury | 2, 8, 13 | |
S.SHR(9) × 4A | Fibrosis | 2, 8, 13 | |
S.SHR(9) × 2B | |||
S.SHR(11) | |||
S.SHR(13) | |||
SS-19SHR | 0.2% or | Proteinuria | 19 |
4% NaCl | Albuminuria | 19 | |
SS- × BN | 0.4% or 4% or 8% NaCl | Proteinuria/albuminuria (m) | 1, 5–8, 11, 13, 16, 18, Y |
Proteinuria/albuminuria (w) | 1–2, 4–14, 16, 18–20 | ||
Structural glomerular injury | 1 | ||
Medullary interstitial fibrosis | 13 | ||
Tubular necrosis | 13 | ||
Glomerulosclerosis | 13 | ||